#CICON24 | Day 1 | Dr. Luis Diaz

In this clip from CICON24, Dr. Luis Diaz from Memorial Sloan Kettering Cancer Center discusses the groundbreaking potential of immunoablative neoadjuvant therapy. This innovative approach uses the power of the immune system to target and shrink tumors to a manageable size before surgery, offering new hope for patients in the fight against cancer. Watch to learn how immunoablative therapy is transforming cancer treatment and reshaping the future of oncology! #CICON24 #CancerResearch #immunotherapy
--

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.